TLRY - MediPharm Labs Still Hits C$8.5M Despite Sequential Drop More On That In Q3 2023 Financial Report | Benzinga
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of around C$1 million sequentially but an increase of C$1.3 million over the year.
CEO David Pidduck emphasized the company's focus on margins, cost reductions and profitability, noting the strong balance sheet and improved profitability for strategic investments in revenue growth.
Q3 2023 Financial Highlights
- Gross profit of C$2.4M or 28%, positive for the fourth consecutive quarter and the highest ...